Urania Therapeutics closes a €3.5M initial seed round - 11/6/2019
Combining venture capital and capabilities in kind for drug development, this innovative operation will help fund the development of promising readthrough compo ...
Mechanism of ribosome shutdown by RsfS in Staphylococcus aureus revealed by integrative structural biology approach - 04/16/2020
Microbial diseases pose a major threat to humanity as COVID 19 demonstrates. Staphylococcus aureus resistance to this day remains at the origin of many infectious d ...
New MicroED Service for structural elucidation of small molecules - 05/18/2020
Micro electron diffraction (microED) provides full 3D crystal structure of small molecules using only fine powders in contrast to the large crystals required for X-ray diffraction.
The NovA ...
NovAliX is a Contract Research Organization with chemistry and biophysical techniques. The integrated drug discovery solutions serve pharmaceutical, biotechnology companies and research institutions. Our commitment and reliability are much appreciated by a worldwide client base.